Clinical Trial Update: Safety and Efficacy of NK510 to Treat Gastric Cancer and Colorectal Cancer [EARLY_Phase 1]

View source ↗

Summary

This document outlines an early Phase 1 clinical trial evaluating NK510 for safety and efficacy in gastric cancer and colorectal cancer, with the study currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Gastric Cancer

Drugs mentioned

• NK510

Snippet

Sponsor: Base Therapeutics (Shanghai) Co., Ltd. | Conditions: Gastric Cancer (GC), Colorectal Cancer | EARLY_Phase 1 | Status: NOT_YET_RECRUITING